Blood biomarker helps estimate a person's future risk of cognitive impairment
A blood biomarker for Alzheimer's disease may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia over the next five or 10 years, according to a new Mayo Clinic study in JAMA Neurology.
Read original article on The Medical News →